Meeting the New Commission on Cancer Operative Standards: Where Do We Stand Now?

Area of Science:

• Oncology
• Surgical Oncology
• Accreditation Standards

Background:

• The Commission on Cancer (CoC) introduced new standards (5.7 and 5.8) for total mesorectal excision (TME) in rectal cancer and lymph node sampling in lung cancer.
• These standards are crucial for ensuring quality cancer care and patient outcomes.
• Compliance with these standards is mandatory for accredited cancer programs.

Purpose of the Study:

• To evaluate institutional adherence to CoC accreditation standards 5.7 and 5.8 for rectal and lung cancer resections.
• To identify compliance gaps and implement corrective actions.
• To offer recommendations for other military training facilities preparing for accreditation.

Main Methods:

• A retrospective chart review of 12 rectal and 48 lung cancer cases (2018-2020) was conducted.
• Deficiencies in operative and pathology reports were identified.
• Interventions were implemented, and compliance was reassessed.

Main Results:

• Pre-intervention compliance was 58% for rectal cancer (standard 5.7) and 35% for lung cancer (standard 5.8).
• Key deficits included inadequate synoptic reporting and lymph node sampling.
• Post-intervention, compliance reached 100% for both standards.

Conclusions:

• The institution successfully improved compliance with CoC standards through targeted interventions.
• Improvements in documentation and systematic lymph node sampling were critical.
• Military facilities should proactively assess their compliance with these standards to prepare for accreditation site visits.